ARCHIVES

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

Review Planned Of 54 Deaths In First 60 Days On Studies.

June 22, 2001

Resource Offered for DNA Probe Mapping

August 14, 1987

Top NCI Officials Pledge No Further Consolidation of Clinical Trials System

December 5, 2014

In Brief: White House Appoints Six to NCAB; Calabrisi To Succeed Korn As Chairman; 2 Spaces Vacant

January 25, 1991

Keytruda Granted Approval In Metastatic Melanoma

September 26, 2014

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

July 28, 2006